Management of common adverse effects of antipsychotic medications

Stroup, T. Scott, Gray, Neil·2018·World Psychiatry
DOI 10.1002/wps.20567

Cited by (572)

Items 401–500 of 572

  1. Exploring the experiences of mental health nurses in the management of schizophrenia in the Upper East Region of Ghana: a qualitative study
    Dennis Bomansang Daliri, Timothy Tienbia Laari, Nancy Abagye, Agani Afaya · 2024 · BMJ Open
  2. Risk-aware restricted outcome learning for individualized treatment regimes of schizophrenia
    Shuying Zhu, Weining Shen, Haoda Fu, Annie Qu · 2024 · The Annals of Applied Statistics
  3. Reasons for switching oral antipsychotic medications and related patterns of care and costs in patients with schizophrenia initiating monotherapy treatment: Claims-linked chart study
    Rebecca M. Fee, Noah S. Webb, Laura Dick, John C. White, Breanna Essoi, Valery Walker, Christopher Zacker · 2024 · Journal of Managed Care & Specialty Pharmacy
  4. Acute Urinary Frequency in a Cancer Patient on Olanzapine
    Kristy Nguyen, Eduardo D Bruera · 2024 · Journal of Pain and Symptom Management
  5. Imipramine Increases Norepinephrine and Serotonin in the Salivary Glands of Rats
    Kosuke Shirose, Masanobu Yoshikawa, Takugi Kan, Masaaki Miura, Mariko Watanabe, Mitsumasa Matsuda, Hiroyuki Kobayashi, Mitsuru Kawaguchi, Kenji Ito, Takeshi Suzuki · 2024 · Biology
  6. A conceptual framework for psychiatric nurses to facilitate medication compliance among adults living with depression
    Jeanne M. du Plessis, Annie M. Temane, Marie Poggenpoel · 2024 · Curationis
  7. Genetic determinants of antidepressant and antipsychotic drug response
    Hans H. Stassen, Silke Bachmann, René Bridler, Katja Cattapan, Annette M. Hartmann, Dan Rujescu, Erich Seifritz, Matthias Weisbrod, Chr. Scharfetter · 2024 · European Archives of Psychiatry and Clinical Neuroscience
  8. Evaluation of routine health monitoring for metabolic disorders in patients with serious mental illness on psychotropic medications: a study from Ethiopia
    Tirsit Ketsela Zeleke, Abel Hedato Teshome, Meron Tademe Assefa, Gashaw Sisay Chanie, Rahel Belete Abebe · 2024 · BMC Psychiatry
  9. Effectiveness and Safety of Suvorexant in Preventing Delirium: A Systematic Review and Meta-Analysis
    Lu Yin, Guangyou Lv, Ruijun Han, Yong Zhang, Xia Du, Yanying Song, Jie Zhang · 2024 · Journal of Clinical Question
  10. Movement Disorders Associated with Levosulpiride: A Systematic Review of Prevalence, Risk Factors, and Therapeutic Approaches
    Madhusudan Prasad Singh, Manisha Maheshwari, Sushant Saurabh, Juhi Singh · 2025 · Neurology India
  11. Enhancing Cognition, Self-Efficacy, and Postural Control Skills of Persons with Schizophrenia Spectrum Disorders Using Immersive Puzzle Video Games
    Jen-Suh Chern, Yu Yang, Chien-Chun Chu · 2025 · Games for Health Journal
  12. Psychosocial Interventions Impact on Cardiometabolic, Neurobiological, Behavioral, and Immune Outcomes in People With a Serious Mental Illness: A Systematic Review
    Julia C. Hill, Crystal M. Noller, Paul E. Holtzheimer, Krista D. DiSano, Ella Klinsky, Mona Pudasaini, Hannah Crowe‐Cumella, Karen L. Fortuna · 2025 · Health Science Reports
  13. Changes in Psychotropic Prescribing for Patients With Dementia, 2014–2016: Potential implications for Pharmacists
    Nicole K. Early, Kathleen A. Fairman, Justin Ma, Kevin Hong · 2020 · The Senior Care Pharmacist
  14. Overcoming Complications in Management of a Difficult-to-Treat Adolescent with Schizoaffective Disorder
    Michelle Miller, Nadege Barbe, Raul J. Poulsen, Barbara J. Coffey · 2020 · Journal of Child and Adolescent Psychopharmacology
  15. Autoimmune Encephalitis in a Girl With Psychiatric Manifestations
    Anum Haider, Areeba Rehman, Summaiyya Waseem, Saad Khalid · 2021 · Cureus
  16. Prise en charge pharmacothérapeutique de la schizophrénie à l’intention des médecins de famille
    Japheth Bool, Alex Crawley, Annabelle Wanson, Breanna Davis, Katelyn Halpape · 2021 · Canadian Family Physician
  17. A Case of Hyperpyrexia Associated With Risperidone Microspheres for Injection (II)
    Xiangyuan Diao, Dandan Wang, Shaojia Lu, Shaohua Hu, Jianbo Lai · 2022 · Journal of Clinical Psychopharmacology
  18. 11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology
    2019 · Psychiatry and Clinical Psychopharmacology
  19. A case of antipsychotic‐induced psychomotor seizure
    Yanqun Zheng, Xiaohua Liu, MingLiang Ju · 2022 · General Psychiatry
  20. Биохимические аспекты применения дополнительной фармакотерапии при лечении психозов позднего возраста
    И. С. Бокша, V. Sheshenin, Olga Konstantinovna Savushkina, Е. Б. Терешкина, T. A. Prokhorova, Почуева Валерия Витальевна, E. A. Vorobyeva, Gulnur Sh. Burbaeva · 2022 · Сибирский вестник психиатрии и наркологии
  21. Rational Psychopharmacological and Psychotherapeutic Treatment of a 14-Year-Old Female with Functional Neurological Symptoms Disorder and Depression
    Sean E. Oldak, Julia Alexis Bernal, Yasin Bez, Barbara J. Coffey · 2023 · Journal of Child and Adolescent Psychopharmacology
  22. Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning
    Pernille Kølbæk, Ole N Mors, Christoph Ulrich Correll, Søren Dinesen Østergaard · 2023 · Schizophrenia
  23. Neuromodulators in food ingredients: insights from network pharmacological evaluation of Ayurvedic herbs
    Choudhary, Neha, Vikram Singh · 2021 · arXiv (Cornell University)
  24. Leading a Satisfactory Life with Schizophrenia
    Mary V. Seeman · 2024 · Springer eBooks
  25. Spotlight commentary: The role of therapeutic drug monitoring in optimizing treatment with antipsychotic medicines
    Jelcic Nina, Robert Likić, Tripkovic Mara · 2024 · British Journal of Clinical Pharmacology
  26. Bayesian Mendelian Randomization Analysis for Latent Exposures Leveraging GWAS Summary Statistics for Traits Co-Regulated by the Exposures
    Yue Yu, Andrew Lakkis, Bingxin Zhao, Jin Jin · 2024 · medRxiv
  27. Schizophrenia and Related Psychoses
    2025 · Wiley eBooks
  28. CORTICOSTEROIDS - (UN)PREDICTABLE INDUCERS OF PSYCHIATRIC DISORDERS
    Tatyana Telbizova, Mariana Arnaoudova · 2019 · Journal of IMAB - Annual Proceeding (Scientific Papers)
  29. Analytical review of side effects and lethal cases of acute poisoning by antipsychotics and antidepressants
    Semion Merzlikin, T. Kucher, V. Stepanenko, O. Pogosyan · 2020 · Ukrainian biopharmaceutical journal
  30. Exploring the Health Status of People with First-Episode Psychosis Enrolled in the Early Intervention in Psychosis Program
    Gin-Liang Chee, D. Wynaden, Karen Heslop · 2020 · Issues in Mental Health Nursing
  31. Персоналізований підхід в терапії психічних розладів: Довгострокові перспективи використання низьких доз психотропних препаратів.
    Azize Asanova · 2020 · Psychosomatic Medicine and General Practice
  32. Manage antipsychotic-induced akathisia by making changes to the antipsychotic drug regimen and/or adding anti-akathisia agents
    Esther S. Kim, Young‐A Heo · 2020 · Drugs & Therapy Perspectives
  33. Comments on “Thalamic Dementia in Acute Inpatient Rehabilitation—Role for Amantadine? A Case Report”
    Min Cheol Chang · 2020 · American Journal of Physical Medicine & Rehabilitation
  34. Персоналізований підхід в терапії психічних розладів: Довгострокові перспективи використання низьких доз психотропних препаратів.
    Azize Asanova, Sofiia Lahutina · 2020 · DOAJ (DOAJ: Directory of Open Access Journals)
  35. Comparative Efficacy, Safety and Tolerability of Olanzapine and Blonanserin in Patients with Schizophrenia: A Parallel Group Study
    S. Chattopadhyay, Uttam Kumar Roy, Supreeti Biswas, P. Roy, P. Mandal · 2021 · Acta Medica Bulgarica
  36. Identification of Risk Factors Associated with Aripiprazole-induced Acute Akathisia
    Masafumi SHIRAHAMA, Shigeru Ishida, Kenichiro Nagata, Hiroyuki A. Watanabe, Toshikazu Tsuji, Kyosuke Miyazaki, Nobuaki Egashira · 2020 · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
  37. Comprehensive Gut Microbiota and Drug Processing
    Susannah Selber‐Hnatiw · 2021 · Elsevier eBooks
  38. Olanzapine: Association Between a Typical Antipsychotic Drug and Aortic Calcification
    Chao Zhang, Dongdong Zheng, Weijing Feng, Huanji Zhang, Feng Han, Wanbing He, Aiting Liu, Hui Huang, Jie Chen · 2021 · Frontiers in Cardiovascular Medicine
  39. Evaluating the efficacy and safety of electro-acupuncture in patients with antipsychotic-related constipation: protocol for a randomized controlled trial
    Fang-Ting Yu, Di-he Long, Guang‐Xia Shi, Li‐Qiong Wang, Jian‐Feng Tu, Li-Li Gang, Fuquan Liu, Yang Wang, Xiao Cui, Si Bao et al. · 2021 · Trials
  40. Two Perspectives of Mental Distress
    John Thor Cornelius · 2021 · Psychoanalytic Inquiry
  41. AN OBSERVATIONAL COMPARATIVE STUDY OF EXTRAPYRAMIDAL SIDE EFFECTS IN PATIENTS TAKING TYPICAL AND ATYPICAL ANTIPSYCHOTICS
    2021 · International Journal of Biology Pharmacy and Allied Sciences
  42. Formulation, Development, and Evaluation of Quetiapine Fumarate Immediate Release Tablets
    Prashant Lakshaman Pingale, Sahebrao Sampat Boraste, Sunil Vishvanath Amrutkar · 2021 · Pharmacophore
  43. The Child with Tics or Other Common Movement Disorders
    Keisuke Ueda, KEVIN JOHN BLACK · 2020 · OSF Preprints (OSF Preprints)
  44. Psychopharmakologische Grundlagen
    Thomas Köhler · 2020 · Springer eBooks
  45. Prevalence and factors associated with overweight and obesity in patients with severe mental disorders in Shenzhen: results from the urban Chinese population
    Xiaodong Peng, Wei Shan, Zhijian Zhou, Guojun Wang, Tiebang Liu · 2022 · Research Square
  46. Akathisia
    Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, Antônio Lúcio Teixeira · 2022 · Oxford University Press eBooks
  47. Case Report: Experience with Cariprazine in Organic Delusional Disorder in an Elderly with Concomitant Somatic Pathology, Brief Report
    E. V. Darin · 2022 · Current Psychiatry Research and Reviews
  48. Schizophrenia Spectrum and Other Psychotic Disorders: Second Wave Case Conceptualization
    Dennis R. Combs, David W. Rose, Michael R. Basso · 2022 · Springer eBooks
  49. Child with Tics and Other Common Movement Disorders
    Keisuke Ueda, KEVIN JOHN BLACK · 2022 · Springer eBooks
  50. 40-Year-Old Man with Dysphagia
    Sara Hooshmand, Emily M. Olson · 2023 · Mayo Clinic Proceedings
  51. Multimethod Assessment of Psychosis and Psychotic Phenomena
    Joni L. Mihura, James H. Kleiger, Ali Khadivi · 2023 · Oxford University Press eBooks
  52. A review of interventional schizophrenia trials registered in clinical trials registry of India
    Ashwini V. Karve, Renita E. Dsilva · 2023 · International Journal of Basic & Clinical Pharmacology
  53. Drug induced psychosis
    Dr Gurpreet Bhamra · 2023 · InnovAiT Education and inspiration for general practice
  54. Cannabidiol as a Treatment for Schizophrenia
    João Roberto Lisboa, João Luís Q. Simei, José Diogo R. Souza, Felipe V. Gomes · 2023 · Psychiatric Annals
  55. Antipsychotic Medication Adverse Effect on Autistic Patients among Saudi Papulation
    Shaima Almufarej · 2023 · International Journal of Current Science Research and Review
  56. Anesthesia in the critical care unit and pain management
    Daniel Beckerman, Henson Destine, Edgar J. Pierre · 2023 · Current Therapy of Trauma and Surgical Critical Care
  57. D-CYCLOSERINE FOR THE TREATMENT OF CHRONIC PAIN
    Jonathan C. Javitt, Michael T. Sapko, MD, PhD · 2023
  58. D-CYCLOSERINE FOR THE TREATMENT OF CHRONIC PAIN
    Jonathan C. Javitt, Michael T. Sapko · 2023
  59. Pharmacology for Stress
    Philippe Fauquet-Alekhine, Jean-Claude Granry · 2023 · Springer eBooks
  60. A comprehensive review on the role of dopamine in the pathophysiology of tardive dyskinesia
    Krishnaveni Kandasamy, Abinaya Paramanandham, Goshika Russel Suthi Kumari, Kameswaran Ramalingam · 2023 · International Journal of Research in Medical Sciences
  61. Coercion and Institutional Racism in the Evolving Mental Health System
    Melissa G. Murphy · 2023 · Oxford University Press eBooks
  62. Haloperidol Decanoate-Induced Pancytopenia: A Case Report
    Amit Jagtiani, Sandra Veigne, Raghu Gandhi, Abid Rizvi · 2023 · Cureus
  63. Evolution of the use of quetiapine
    Aysha Mendes · 2023 · Journal of Prescribing Practice
  64. Schizophrenia and Other Late-Life Psychoses
    Francesco Saverio Bersani, Elisabeth Prevete, Roberto Vicinanza · 2023 · Springer eBooks
  65. The Challenge of Managing Refractory Psychosis Amid Multiple Medication Side Effects: A Case Report and Review of the Literature
    Alejandro Rodulfo, Sabina Goldstein, Zina Meriden · 2023 · Cureus
  66. Farmako antipsikotikoak eta aho-patologia: eragin kaltegarriak jakinarazteko Europako sistemaren bidezko analisia
    Leire Urien, Unax Lertxundi, Teresa Morera‐Herreras, Nerea Jauregizar · 2023 · Osagaiz osasun-zientzien aldizkaria
  67. Aberrant Hippocampal Neuroregenerative Plasticity in Schizophrenia: Reactive Neuroblostosis as a Possible Pathocellular Mechanism of Hallucination
    Mercy Priyadharshini Babu Deva Irakkam, Jerly Helan Mary Joseph, Mahesh Kandasamy · 2023 · Preprints.org
  68. Role of D2 receptor (–141 C Ins/Del) genetic polymorphism on olanzapine-induced adverse drug reaction in schizophrenic patients
    Zahra Jawd Mohammed Ali, Atheer Majid Rashid Al-juhiashi · 2024 · Pharmacia
  69. Management of Severe Mental Illness in the Dental Setting: A Grey Matter?
    Karishma Dusara, Hannah Cousins · 2024 · Dental Update
  70. A Comparative Approach Based on Molecular Docking Interaction of Citalopram and Tianeptine with Serotonin Transporter
    A Iffat · 2023 · Open Access Journal of Pharmaceutical Research
  71. rTMS Shows Efficacy in Improving Negative Symptoms in Early Psychosis: A Systematic Review
    Marianne Hrabok, Anthony K. Hinde, Wei-Yi Song · 2024
  72. Pharmacological Therapy for the Management of Patient Ventilator Asynchrony During Noninvasive Ventilation
    Mohanchandra Mandal, Pradipta Bhakta, John Robert Sheehan, Brian O’Brien, Dipasri Bhattacharya · 2023 · Noninvasive ventilation. The essentials
  73. Pharmacist‐led intervention to reduce inappropriate continuation of targeted medications initiated in the acute care setting at hospital and ICU discharge
    Nandini Patel, Robert E. Dannemiller, Mary P. Kovacevic, Kevin M. Dube, Kenneth E. Lupi, Rachel Blum, Kaitlin E. Crowley · 2024 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  74. Physical Health of Patients with Schizophrenia
    Pavel Mohr, Matej Štuhec, István Bitter · 2024 · Cambridge University Press eBooks
  75. Innovative Sunday School Strategy Shaping the Character of Generation Alpha
    Jemmy Jemmy, Daniel Tatang Effendi · 2024 · World Psychology
  76. Analysis of Psychoanalytic Therapy Intervention: for Individuals with Post Traumatic Stress Disorder (PTSD)
    Rohmat Burhanuddin, Casmini Casmini · 2024 · World Psychology
  77. Bad Influence of the Tretes Localization Area on the Mindset of the Young Generation in Pasuruan: Viewed from Social Learning Theory
    Ersa Nur Amalia, Shinta Nuriyah, Ulul Azmiyah, Nanik Kholifah · 2024 · World Psychology
  78. Psikologlar ve Psikolojik Danışmanlar için Psikofarmakolojiye Giriş
    Yener Özen · 2024 · Akademisyen Kitabevi eBooks
  79. Investigation of Safety Profile of Lurasidone and Olanzapine in Treatment of Schizophrenia
    Divea Sharma, Amit Kumar Nayak, D. D. Dupta, Dinesh Dutt Sharma, Dinesh Dutt Sharma · 2024 · SN Comprehensive Clinical Medicine
  80. Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
    Nazish Sarfraz, Humera Akram, Afroza Abbas, Sadaf Shaheen, Zoobia Ashiq, Eesha Yaqoob · 2023 · Journal of Rawalpindi Medical College
  81. Computational speech markers of negative symptoms show evidence of being robust to antipsychotic dose and extrapyramidal symptoms in schizophrenia
    Michael J. Spilka, Jessica Robin, Amir Hossein Nikzad, Leily Marieh Behbehani, Sarah A. Berretta, Mengdan Xu, John Michael Kane, William Simpson, Sunny X. Tang · 2024
  82. Psychopharmacological Treatment of Schizophrenia
    Nirmal Singh, Suhas Ganesh, Deepak Cyril D’Souza · 2024 · Elsevier eBooks
  83. Ear Dyskinesia in the Absence of Neuroleptics: A Case Report
    Mohammed Azzahrani, Abeer Algasim · 2024 · Cureus
  84. Waist-Height ratio Highlights Detrimental Risk for Olanzapine Associated Weight Gain Earlier than Body Mass Index.
    Badamasi Mohammed Ibrahim, Abiola Tajudeen, Owolabi Desola Shakirat, Margaret Isioma Ojeahere, Asuku Abdullahi Yusuf, Mujittapha Umar Sirajo, Mustapha Ibrahim Gudaji · 2024 · Research Square
  85. Does risperidone causes life threatening pancytopenia? A case report from Nepal
    Bikash Khadka, Kishor Khanal, Krishna Bhusal, Sandip Raj Pradhan, Sabina Shah, Kailash Khatri, Saroj Poudel · 2023 · Bangladesh Critical Care Journal
  86. Chapter 53. Treatment of Schizophrenia
    Mary F. Brunette, Jacob S. Ballon, Samantha A. Gnanasegaram, Agnieszka Kalinowski, William R. Keller, Jeffrey D. Reed, Doug Noordsy · 2024 · American Psychiatric Association Publishing eBooks
  87. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022
    Fariba Farnaghi, Pooya Eini, Latif Gachkar · 2024 · International Journal of Medical Toxicology and Forensic Medicine
  88. Enhancement of Haloperidol-Induced Catalepsy by GPR143, an l-DOPA Receptor, in Striatal Cholinergic Interneurons
    Cassandra J. Hatzipantelis · 2024 · Journal of Neuroscience
  89. Identifying potential dopamine receptor D2 antagonist from Rauwolfia serpentina – An in-silico virtual screening approach
    Souvik Chakraborty, Sushmita Bhowmick, Tarasankar Maiti · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Psychosis in Laurence-Moon Syndrome: A Case Report
    Nojoud Al Fareh, Marwah Abbas, Fahad Dakheel Alosaimi · 2024 · Cureus
  91. Effectiveness of salivary-gland and oral-mucosa massage in alleviating xerostomia in patients with schizophrenia
    Yuki Iwashima, Yutaka Watanabe, Kimiya Ozaki, Eri Arai, Kazuhito Miura, Ayako Yokoyama, Miyako Kondo, Seitaro Nakazawa, Matsuhiko Oka, Kazutaka Okada et al. · 2024 · Journal of Oral and Maxillofacial Surgery Medicine and Pathology
  92. Tratamentul sialoreei induse de clozapină la pacienţii cu schizofrenie – studiu-pilot cu o suspensie extemporanee oromucozală de trospiu
    Daniel Ungureanu, Adina Popa, Maria Bonea, Răzvan Pop, Roland Stretea, Cătălina‐Angela Crișan · 2024 · Psihiatru ro
  93. Prevalence and Factors Associated with Hypersalivation in Schizophrenia Inpatients Treated with Clozapine: A Retrospective Study
    Chanunnat Kitsinthopchai, Siripun Kumpeera, Apiradee Sangngarm, Tuanthon Boonlue · 2024 · Hospital Pharmacy
  94. Utilizing Intranasal Drug Delivery Systems for Novel Antipsychotics Drug Development
    Ahmad Ainurofiq, Priyanto FAP, Bambang Budi Suryadi, Pamungkas YK · 2024 · International Journal of Drug Delivery Technology
  95. Real-World Evidence and Outcomes Associated with Pharmacotherapy in Schizophrenia
    Matthew C. Dickson, Tammy L. Lambert, Grant H. Skrepnek · 2024 · Springer eBooks
  96. Harnessing Data Warehousing for Precision in Off-Label Prescription Detection in Psychiatry (PSYHAMM): Retrospective Proof-of-Concept Evaluation Study
    Emmanuel Chevallier, Catherine Letord A, Jean Charlet, Marie‐Odile Krebs, Emmanuelle Advenier-Iakovlev, Stéfan Jacques Darmoni, Julien Grosjean A, Romain Léguillon · 2026 · JMIR Formative Research
  97. Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia
    Alladi Charanraj Goud, Ravi Philip Rajkumar, Deepak Gopal Shewade, Luxitaa Goenka, Suresh Kumar Srinivasamurthy · 2025 · European Journal of Clinical Pharmacology
  98. Beyond Medication: The Dual Benefits of Physical Activity on Psychosis and Sleep Quality Among Male Patients with Schizophrenia
    Mahmoud Abdelwahab Khedr · 2025 · Issues in Mental Health Nursing
  99. Virtual nurse support to enhance antipsychotic adherence in schizophrenia: A South African perspective
    Yasmeen Thandar, Nomhle Mvunelo, Singh Deepak, Firoza Haffejee · 2025 · South African Journal of Psychiatry
  100. Cognitive and anti-inflammatory effects of Palmaria palmata in a schizophrenia mouse model: insights into CREB signaling, Iba-1 expression, and CD4+ cell modulation
    Shimaa Mohammad Yousof, Badrah Saeed Ali Alghamdi, Thamer Mohammed Ahmed Alqurashi, Mohammad Zubair Alam, Reham Fathy Tash, Noha M. Abd El‐Fadeal, Samy A. Abusikkien, Lamis AbdelGadir Kaddam · 2025 · Frontiers in Neuroscience